CSIMarket Company Name, Ticker, Suppliers, else..
 
Monopar Therapeutics Inc   (NASDAQ: MNPR)
 

Monopar Therapeutics Inc's Suppliers Performance

MNPR's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
MNPR Costs vs Sales of Suppliers Growth

• More on MNPR Suppliers






Monopar Therapeutics Inc's Comment on Supply Chain


The company utilizes elements of the existing supply chain from recent clinical studies for ALXN1840 and has engaged those vendors as contract manufacturers for the supply of API and drug products for MNPR-101-Zr and MNPR-101-Lu. The company recognizes potential risks associated with relying on current sources or identifying replacement third-party manufacturers, including competition for manufacturing capacity and regulatory approval requirements. Manufacturing processes must comply with current Good Manufacturing Practices (cGMP) and pass pre-approval inspections by the FDA, TGA, or other regulatory agencies prior to commercial production. Non-compliance could delay or prevent product approval and market entry.

Monopar Therapeutics Inc's Comment on Supply Chain


The company utilizes elements of the existing supply chain from recent clinical studies for ALXN1840 and has engaged those vendors as contract manufacturers for the supply of API and drug products for MNPR-101-Zr and MNPR-101-Lu. The company recognizes potential risks associated with relying on current sources or identifying replacement third-party manufacturers, including competition for manufacturing capacity and regulatory approval requirements. Manufacturing processes must comply with current Good Manufacturing Practices (cGMP) and pass pre-approval inspections by the FDA, TGA, or other regulatory agencies prior to commercial production. Non-compliance could delay or prevent product approval and market entry.







MNPR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Monopar Therapeutics Inc 824.09 0.00 -17.84 22
SUBTOTAL 0.00 0.00 0.00 -


Sources: Monopar Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Monopar Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.